ADAP - Adaptimmune EPS beats by $0.30 misses on revenue November, 06 2019 07:40 AM Adaptimmune Therapeutics plc Adaptimmune (NASDAQ:ADAP): Q3 GAAP EPS of -$0.06 beats by $0.30.More news on: Adaptimmune Therapeutics plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...